Now accepting Telehealth appointments. Schedule a virtual visit.

TMS and its Effect on Insomnia

Many patients with treatment resistant depression have coexisting symptoms of insomnia that may have preceeded their depression and could increase their risk of relapse. Those with insomnia also have a higher chance to develop depression in addition to suicidal ideation. In the paper by Suh et al. 2013, they reported in their 6 year follow-up study that those who demonstrated two or more episodes of insomnia in non-depressed patients saw an increase risk of both depression and suicidal ideation. However, there are reports that show the improvements in patients with primary insomnia when treated with Transcranial Magnetic Stimulation (TMS). Sanchez-Escandon et al. 2014 reported that their patients with idiopathic insomnia saw improvements in total sleep time, sleep efficiency, sleep onset latency, total wake time, and wake time after sleep onset. 

TMS is approved for Depression, however it does have offlabel affects on anxiety, insomnia, and OCD. Give us a call today for more information and how to get started with the Treatments. 

 

Read the whole article here: https://www.clinicaltmssociety.org/news/2019-11/tms-and-insomnia

 

References: 

Suh S, Kim H, Yang H-C, Cho ER, Lee SK, Shin C. Longitudinal Course of Depression Scores with and without Insomnia in Non-Depressed Individuals: A 6-Year Follow-Up Longitudinal Study in a Korean Cohort. Sleep. 2013;36(3):369-376. doi:10.5665/sleep.2452

Snchez-Escandón O, Arana-Lechuga Y, Terán-Pérez G, et al. Transcraneal Magnetic Stimulation Improves Sleep Parameters in Patients Affected with Imsomnia Associated to Electroencephalographic Abnormalities. Neurosci Med. 2014;05(01):72-77. doi:10.4236/nm.2014.51010

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).